Moreover, inhibited p38MAPK can inhibit TGF-β-induced Smad2/3 phosphorylation and a-SMA expression, and reduce the pressure overload-induced cardiac hypertrophy and fibrosis in the left ventricle (Turner and Blythe, 2019). Here, TGFB1 is linked to cardiac hypertrophy.